A Look at Interpublic Group’s (IPG) Valuation After Major Bayer Client Win Signals Operational Momentum

Bayer’s Consumer Health division recently selected Interpublic Group of Companies (NYSE:IPG) as its global agency partner, giving IPG responsibility for creative, production, and media for widely recognized self-care brands. This client win highlights IPG’s competitive positioning and potential for increased revenue.

See our latest analysis for Interpublic Group of Companies.

In the bigger picture, Interpublic Group’s recent momentum is driven not only by the substantial Bayer partnership, but also by industry-wide buzz around its potential merger with Omnicom and a series of global data security certifications. Still, the latest 1-year total shareholder return is down nearly 10%, a reminder that while operational wins are accumulating, the market remains cautious about longer-term growth prospects. Overall, IPG’s short-term news flow has drawn attention, but total shareholder returns over five years show a steady climb. This suggests that patient investors may continue to see value as the company evolves.

If you’re looking for more companies making strategic moves and capturing investor attention, now could be the right moment to discover fast growing stocks with high insider ownership.

With IPG trading at a notable discount to analyst targets but still facing a tepid one-year return, investors may wonder whether the current valuation presents a rare entry point or if markets have already anticipated future earnings growth.

Most Popular Narrative: 20% Undervalued

With the narrative’s estimated fair value at $33.14 and the last close at $26.50, the consensus points to notable upside from current levels. Investors are watching as projected earnings and margin expansion become key to justifying this view.

The company's accelerated integration of AI and data-driven platforms (such as Interact and the new ASC for commerce) is expanding high-margin, tech-enabled service offerings and unlocking new revenue streams (e.g., SaaS fees, performance-based compensation), with adoption rates increasing across the organization. This is likely to support future revenue growth and margin expansion.

Read the complete narrative.

Want the full story behind this potential value gap? The narrative’s price target is underpinned by assumptions about profits and margins that may surprise even seasoned investors. Curious which projections make the difference? Only by digging into the full narrative will you see the bold moves and aggressive forecasts that underpin the fair value calculation.

Result: Fair Value of $33.14 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, risks such as ongoing client losses and industry disruption could still undermine Interpublic Group's growth story and challenge bullish forecasts.

Find out about the key risks to this Interpublic Group of Companies narrative.

Build Your Own Interpublic Group of Companies Narrative

If you want to put your own spin on the numbers or test these assumptions yourself, you can create your own narrative in just a few minutes. Do it your way.

A great starting point for your Interpublic Group of Companies research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Looking for More Investment Ideas?

Stay ahead of the curve by checking out these exciting opportunities. You could uncover your next big winner before the crowd catches on.

• Catch rising stars with untapped growth potential by reviewing these 896 undervalued stocks based on cash flows, where value still lies beneath the surface.
• Get ahead of tomorrow's health innovations and see which companies are transforming medicine with next-level intelligence through these 32 healthcare AI stocks.
• Secure more income from your portfolio by scanning these 19 dividend stocks with yields > 3% that consistently deliver strong, reliable yields above 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com